Advancing diabetes treatment: novel formulation of polydatin long-circulating liposomes and their glucose-regulating impact on hyperlipidemia-induced type 2 diabetic mice-Reference-Cited by-同舟云学术

Advancing diabetes treatment: novel formulation of polydatin long-circulating liposomes and their glucose-regulating impact on hyperlipidemia-induced type 2 diabetic mice

Published:2024 Issue:16 Volume:5 Page:6516-6534
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Zhang Kepei¹,Chen Junlan¹,Raza Faisal²^ORCID,Zafar Hajra²,Xu Ye¹,Li Ran³,Hidayat Ullah Kamran⁴,Zhou Shigao¹

Affiliation:

1. Department of Internal Medicine of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725 Wanping South Road, Xuhui District, Shanghai, 200032, China

2. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

3. Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang, 212016, Jiangsu, China

4. Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar, Pakistan

Abstract

Polydatin, a monomer derived from the dried roots and stems of traditional Chinese medicinal herb, Polygonum cuspidatum, boasts extensive pharmacological activities.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D4MA00020J

Reference95 articles.

1. Effect of artesunate on cardiovascular complications in periodontitis in a type I diabetes rat model and related mechanisms

2. Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes

3. The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes

4. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

5. Trends and regional differences in glycemic control of patients with type 2 diabetes in China, 2009–2013